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a b s t r a c t
TGF-beta (TGFβ) family mediated Smad signaling is involved in mesoderm and endoderm speciﬁcations,
left–right asymmetry formation and neural tube development. The TGFβ1/2/3 and Activin/Nodal signal
transduction cascades culminate with activation of SMAD2 and/or SMAD3 transcription factors and their
overactivation are involved in different pathologies with an inﬂammatory and/or uncontrolled cell
proliferation basis, such as cancer and ﬁbrosis. We have developed a transgenic zebraﬁsh reporter line
responsive to Smad3 activity. Through chemical, genetic and molecular approaches we have seen that
this transgenic line consistently reproduces in vivo Smad3-mediated TGFβ signaling. Reporter ﬂuores-
cence is activated in phospho-Smad3 positive cells and is responsive to both Smad3 isoforms, Smad3a
and 3b. Moreover, Alk4 and Alk5 inhibitors strongly repress the reporter activity. In the CNS, Smad3
reporter activity is particularly high in the subpallium, tegumentum, cerebellar plate, medulla oblongata
and the retina proliferative zone. In the spinal cord, the reporter is activated at the ventricular zone,
where neuronal progenitor cells are located. Colocalization methods show in vivo that TGFβ signaling is
particularly active in neuroDþ precursors. Using neuronal transgenic lines, we observed that TGFβ
chemical inhibition leads to a decrease of differentiating cells and an increase of proliferation. Similarly,
smad3a and 3b knock-down alter neural differentiation showing that both paralogues play a positive role
in neural differentiation. EdU proliferation assay and pH3 staining conﬁrmed that Smad3 is mainly active
in post-mitotic, non-proliferating cells. In summary, we demonstrate that the Smad3 reporter line allows
us to follow in vivo Smad3 transcriptional activity and that Smad3, by controlling neural differentiation,
promotes the progenitor to precursor switch allowing neural progenitors to exit cell cycle and
differentiate.
& 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
Introduction
TGFβ1/2/3, Activin/Nodal and BMP signaling belong to the
TGFβ family. All three signaling subfamilies show a similar
transduction pathway: the secreted ligands interact with type I
and II transmembrane serine-threonine kinase receptors.
The type II receptors phosphorylate type I receptor, which in turn
permits the binding of receptor-regulated transcription factors
SMADs (R-SMADs) and their subsequent phosphorylation at the C-
terminus. Activated R-SMADs can interact directly with a common
mediator, SMAD or Co-SMAD (SMAD4), and then translocate into
the nucleus to directly target gene expression (Moustakas and
Heldin, 2009).
BMP, Activin/Nodal and TGFβ1/2/3 signaling require different
ligands, type II receptors (ALK1, 2, 3 and 6 for BMP; ALK4, 5 and 7 for
TGFβ1/2/3 and Activin/Nodal) and R-SMADs (SMAD1, 5 and 8 for BMP;
SMAD2 and 3 for TGFβ1/2/3 and Activin/Nodal) (Hinck, 2012). As a
consequence, gene sequences recognized by R-Smads are different for
the two signaling pathways. In zebraﬁsh two smad3 isoforms are
known: smad3a and 3b. They are the result of the genome duplication
that occurred during teleost evolution. These two genes show a partially
overlapping expression: they are both expressed in the tail bud and
lateral stripes of the forming mesoderm; however, Smad3a is also
produced in an additional area that surrounds the tail bud (Dick et al.,
2000). Their mechanisms are similar and they are expressed in over-
lapping and non-overlapping tissues (Pogoda and Meyer, 2002) dis-
playing additive genetic effects.
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All the TGFβ1/2/3 and Activin/Nodal R-smads and smad4
transcripts are ubiquitously expressed since blastula stage as a
consequence of their maternal origin (Dick et al., 2000). However,
during gastrulation, they are either transcribed at very low level
(smad2), or almost undetectable (smad3a and 3b) (Dick et al.,
2000; Pogoda and Meyer, 2002). In contrast, smad4 expression is
high in all these stages (Dick et al., 2000). From tail bud stage
smad3a and 3b mRNA production increases (Hsu et al., 2011). At
late somitogenesis (16 hpf) smad3a mRNA is mainly conﬁned to
the eyes and tail region, although present at low levels throughout
the embryo. smad3b is expressed in the same areas, but it has a
higher rate of expression overall (Hsu et al., 2011). Both smad2 and
4 are present in the entire embryo, but particularly in the tail
region, the eye and the brain (Hsu et al., 2011). However, smad2
and 3 expression is necessary but not sufﬁcient for correct
functionality: a signal transduction cascade leading to their
phosphorylation is needed (Liu et al., 1997).
Although Smad2 and 3 share a highly similar protein structure
(more than 90% amino acid sequence identity), they are involved
in different physiological and pathological processes. Smad2
knockout mice fail to form mesoderm and endoderm demonstrat-
ing the importance of this transcription factor in early develop-
ment (Nomura and Li, 1998). Smad3 knockout mice, while viable,
have chronic intestinal inﬂammation producing colorectal cancer
and metastasis (Zhu et al., 1998). Therefore, Smad3 transcription
factor seems to be associated to the immune system and it might
regulate cell cycle working as tumor suppressor. These different
roles correlate with their slightly different structure. Smad2
contains an inhibitory region in the MH1 region that hinders
direct DNA binding. In contrast, Smad3 recognize Smad Binding
Element (SBE) boxes that were used for the creation of the
Smad3-responsive line of this work. Furthermore, a Smad2 alter-
native splicing variant missing the inhibitory domain has been
reported. This variant would bind DNA directly and is possibly
responsible for Smad2's impact during development (Dunn et al.,
2005; Lee et al., 2011).
R-SMADs activity is regulated by inhibitory-SMADs (I-SM ADs).
For TGFβ, SMAD7 functions as a negative signaling regulator
(ten Dijke and Hill, 2004). The inhibitory factor SMAD7 is induced
by SMAD3 and provides a negative feedback loop to the pathway.
In zebraﬁsh, smad7 shows a pattern of expression similar to that
observed for smad3b, underlying the reciprocal functional connec-
tion between the two genes. smad7 is ubiquitously present as
maternal transcripts until gastrula stage, when its expression
decreases, becoming limited to the ventral side of the embryo,
though expression increases in the tail bud (Pogoda and Meyer,
2002). SMAD7 can act in different ways: it can compete with
R-SMADs for binding type I receptors; it can recruit E3-ubiquitine
ligases (SMURF1 and 2) to the activated type I receptors causing
their degradation (ten Dijke and Hill, 2004).
TGFβ signaling is involved in a wide range of physiological and
pathological processes in both embryonic and adult stages. It acts
as a morphogen through Nodals and Activins directing the
patterning of the three germ layers (Watabe and Miyazono,
2009). A dysregulation of this pathway is associated with tumor-
igenesis, ﬁbrosis, allergic response and neurodegenerative dis-
eases. Both in physiological and pathological conditions, its effect
depends on the tight regulation of the cell cycle (Fleisch et al.,
2006). TGFβ signaling is a well-known pro-apoptotic signal, it
promotes epithelial-to-mesenchymal transition (EMT) (Song,
2007) and SMAD4 is a powerful tumor suppressor in pancreatic
tumors (Herman et al., 2013). In the etiopathogenesis of neurolo-
gical disorders the role of SMAD3/TGFβ signal is not so clear; TGFβ
signaling disruption is correlated with several motor neuronal
diseases, because of the neuroprotective and anti-inﬂammatory
effects of this pathway (Katsuno et al., 2011). Its overactivation is
associated with the formation of β-amyloid plaques in Alzheimer's
disease (Town et al., 2008). TGFβ seems to be involved in glial
differentiation and production of extracellular matrix (ECM) com-
ponents for the scaffolding of neurons in the neural tube. More-
over, it is also a neurotropic factor that stimulates neurogenesis
and axon growth (Gomes et al., 2005).
Dennler et al. have found speciﬁc binding sequences for SMAD3
in the hPAI gene promoter (Dennler et al., 1998). These sequences
(so-called CAGA box) are speciﬁcally recognized by the SMAD3/
SMAD4 complex. Due to an intrinsic steric hindering, SMAD2
cannot interact directly with CAGA box (Dennler et al., 1998).
Taking advantage of this speciﬁcity, we have developed transgenic
reporter lines containing multimerized “CAGA box” to study in vivo
Smad3-mediated signaling. Genetic, pharmacological and mole-
cular analyses show that in these transgenic lines the reporter
gene is activated in a Smad3/TGFβ-responsive manner. During
embryo development, reporter expression was mainly found in the
central nervous system (CNS). In order to determine the role of
TGFβ in neural development, we have performed a series of
experiments using the Smad3-responsive line crossed with trans-
genic ﬁsh lines reporting different stages of the progenitor to
precursor development. To take advantage of all potentialities of
transgenic lines in reporting ﬂuorescent signal dynamics, the
majority of analyses have been performed in vivo. Results show
that postmitotic activation of TGFβ in neural cells controls the
progenitor to precursor transition. Finally, we predict that this line
might be a valuable tool in drug screening as well as in regenera-
tion and cancer research.
Materials and methods
Animals
Animals were staged and fed as described by Kimmel et al. (1995).
The project was examined and approved by the Ethics Committee of
the University of Paduawith protocol number 18746. one-eyed pinhead
(oepm134) (Schier et al., 1996) and chordin (dintt250) (Schulte-Merker
et al., 1997) mutant carriers were identiﬁed both by PCR analysis and
phenotype screening of their offspring at 24 hpf. For oep PCR screen-
ing, the following primers were used: oepm134-wtFw (50-GGCTCC
CTCAGAACACTGTC-30), oepm134-mutRv (50-GGCTCCCTCAGAACACT
GTA-30) and oepm134-Rv (50-CTCTTGGGCACAAAAGAGAA-30). For dino
PCR screening, the following oligonucleotides were used: dino-Fw
(50-GACACAAATGCGGGGTAAAC-30), dino-Rv (50-ATGTTGCAACTCAG-
CAGCAG-30), dino-wtRv (50-CTGTGCACAACTCAC-30) and dino-mutRv
(50-ACTGTGCACAACTCAC-30). For functional in vivo studies we used
the following transgenic lines: Tg(ngn1:GFP)sb1, Tg(mnx1:GFP)ml2. For
neuroD, we used the Tg(2.4 kb neurod:EGFP) line previously pro-
duced in our lab (see also Ronneberger et al., 2012): brieﬂy, the 2.4 kb
promoter of zebraﬁsh NeuroD coding gene was cloned in the pG1
vector and the resulting linearized plasmid injected in fertilized eggs.
The F1 progeny was screened for GFP expression in the CNS. For
smad7 overexpression, we used the Tg(hsp70:smad7-YFP) line (not
published, see below). For all the described experiments, heterozygous
embryos and larvae were used.
Generation of Tg(12xSBE:EGFP)ia16 and Tg(12xSBE:nls-mCherry)ia15
lines
12 repeats of a Smad3-binding sequence, so called CAGA box
(Dennler et al., 1998), were ampliﬁed together with major late
promoter Adenovirus (MLP) with the attB4cagafor (50-GGGGA-
CAACTTTGTATAGAAAAGTTGGCCCGGGCTCGAGAGCCAG-30) and attB1-
cagarev (50-GGGGACTGCTTTTTTGTACAAACTTGTTGGAAGAGAGTGAGG
ACGAA-30) oligonucleotides and then cloned into a pDONOR™ P4-P1R
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according to the manufacturer's guidelines (Invitrogen Multisite Gate-
way System, CA). The resulting Gateway 50 entry vector was recom-
bined with a middle entry vector containing a reporter gene (EGFP, nls-
mCherry), pME vector (pME-EGFP, pME-nlsmCherry), and a 30 entry
vector containing SV40-polyA sequence (p3E-polyA) (Kwan et al.,
2007). 25–50 pg of the obtained Tol2 vector containing Smad3-
responsive sequences was co-injected together with 25 pg of in vitro
synthesized Tol2 Transposase mRNA into one-cell stage wild-type
embryos. Mosaic transgenic ﬁsh were selected at approximately 24 h
post-fertilization (hpf) for ﬂuorescent expression and raised to the
adult stage for screening. Positive founders were selected for the
ﬂuorescence level of their offspring in areas of known Smad3 activity
and by checking responsiveness of reporter expression to SB-431542
(S4317, Sigma, MO), a known Alk4- Alk5-inhibitor (Fig. 1). One allele
for each EGFP and nls-mCherry reporter line was selected and used to
follow in vivo Smad3-mediated TGFβ signaling.
Chemical treatment and RNA in situ hybridization
SB431542 (S4317, Sigma, MO), LY364947 (L6293, Sigma, MO) and
LDN193189 (SML0559, Sigma, MO) were solubilised in pure DMSO to
100 mM, 6 mM and 10 mM ﬁnal concentrations, respectively. For
treatment at 24 hpf, SB431542, LY364947 and LDN193189 were
diluted in zebraﬁsh ﬁsh water containing 2 mM 1-phenyl-2-
thiourea (PTU) to have working solutions of 100 mM, 40 mM and
10 mM, respectively. For LY364947 treatment at 2 hpf, we used a ﬁnal
concentration of 10 mM in zebraﬁsh ﬁsh water. Treatments were
carried out in 6 or 24 well-plates. When needed, embryos and larvae
were ﬁxed in 4% paraformaldehyde (PFA)/PBS overnight at 4 1C and
then stored in pure methanol at 20 1C. Whole mount RNA in situ
hybridizations were performed as described before (Thisse et al.,
1993). EGFP probe was produced using DIG-labeled ribonucleotides,
T7 RNA polymerase and linearized pME:EGFP supplied by Tol2 kit.
Fig. 1. D12xSBE lines are reporters of TGFβ signaling. (A) Brightﬁeld, ﬂuorescence and in situ hybridization lateral views of Tg(12xSBE:EGFP)ia16 embryos at 15, 26 and 48 hpf,
anterior to the left. GFP expression appears in late somitogenesis in the tail and cardiac mesoderm region. At 26 hpf GFP is visible in the telencephalic region and expressed
in the embryo neural tube and tail. At 48 hpf reporter expression is extended to the entire neural tube, maintaining a decreasing gradient from the tail, and in some areas of
the brain. Transcription (in situ) and translation (GFP) patterns are coherent. (B) Fluorescent images of 3 dpf larvae of Tg(12xSBE:EGFP)ia16 (in green) and Tg(12xSBE:
nlsmCherry)ia15, (in red) either treated with the Alk4- and Alk5-inhibitor SB431542 or with carrier (DMSO) for two days: lateral views, anterior to the left. C. RNA in situ
hybridization for EGFP mRNA performed in embryos of Tg(12xSBE:EGFP)ia16 treated at 24 hpf with the Alk4- and Alk5-inhibitor, SB-431542 and ﬁxed at different time points:
2, 4, 6, 8 h post treatment (hpt).
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Morpholinos injections
smad2, 3a and 3b knock-down were carried out injecting morpho-
linos previously tested by Jia et al. (2008): MO-smad2 50-TTACCCTTCC-
TACGAAAAGCGTTCT-30, MO-smad3a 50-TTCAGTTCAGCGTTCCTTCCTCTA
TTGC-30 and MO-smad3b 50-TTGTCCACGAGTCACATCACCGCAT-30. For
coinjection of smad2 and smad3a morpholinos, lower doses of each
one were injected in 1–2 cell stage embryos of Tg(12xSBE:EGFP)ia16.
For the study of putative co-interaction between smad2 and 3a
morpholinos, the lowest doses associated with the minimal
percentage of malformed embryos (lowest effective doses) were
used to prepare the morpholinos mix.
For smad4, GeneTools, LLC, OR synthesized four different morpho-
linos targeting this gene at either the start-codon or one of three
different splicing sites: MO4(1) 50-TCTCGCCCACCTGAACGTCCATCTC-30,
MO4(2) 50-TACTGATGTTGACGCTCTACCTCGC-30, MO4(3) 50-GCA
GTCTGAAAACAGAGAAGTCAGA-30 and MO4(4) 50-GTGTATGTGTTT
CTCACCTTGATGT-30. All of them were injected in drops of 500 pL at
1 mM concentration in Tg(12xSBE:EGFP)ia16 eggs. Effects on embryo
morphology and EGFP expression were observed at 24 hpf. MO4
(3) was used for in vivo experiments at lower concentration
(0.5 mM). To verify its ability to control BMP signaling, it was also
tested in the Tg(BMPRE:EGFP)ia18 line. As a control, we injected the
generic control morpholino supplied by GeneTools (MO-CTL).
smad2 and 4 morpholinos target a splicing site. Therefore, they
have been further validated through RT-PCR. For smad2, the
following primers have been used: Fw 50-GGCTACAGTGGGAAG-
GAAAA-30 and Rv 50-GGTATCCCACTGTTCTATCGTATTT-30. For smad4,
the following primers have been used: Fw 50-GCGTCCAGCTG-
GAGTGTAAA-30 and Rv: 50-CGATCCAGCAGGGCGTCTCTTT-30.
smad3a and 3b morpholinos target the start codon. Therefore,
they have been further validated through whole-mount immunohis-
tochemistry for phospho-Smad3 (ab52903, Abcam, Cambridge, UK).
smad2, 3a, 3b and 4 mRNAs injections
smads coding cDNA are contained in pCS2þ plasmids. Each
plasmid was digested with a speciﬁc restriction enzyme (EcoRI/
XhoI for smad2, 3b and 4 plasmids; BamHI/EcoRI for smad3a
plasmid) and then used for gene transcription through SP6 RNA
polymerase (AM2071, Lifetechnology, CA). Four different dilutions
(100, 50, 20 and 1 ng/ml) of each mRNA was injected in drops of
500 pL in 1–2 cell stage embryos of Tg(12xSBE:EGFP)ia16 line. Their
effect on GFP expression was evaluated at 24 hpf at the epiﬂuor-
escent microscope.
Heat-shock induced overexpression of smad3b and smad7
Cloning of hsp70:Smad7-hsp70:YFP and hsp70:smad3b-hsp70:
YFP constructs: pCS2þ containing full- length smad7 cDNA or PCR-
modiﬁed coding region of smad3bwere linearized and cut to insert
an hsp70:YFP cassette. In a second step smad3 or smad7-hsp70:YFP
was cut out and cloned into the EcoRV/Acc651 sites of the hsp70
containing vector p2hsp70 (gift from Nico Scheer and Jose Cam-
pos-Ortega). The hsp70:smad7-hsp70:YFP containing vector was
injected in 1–2 cell stage embryos to obtain a stable transgenic
line: Tg(smad7-hsp70:YFP).
To validate the Tg(12xSBE:nls-mCherry)ia15 line, we stimulated
overexpression of smad3b and smad7: we injected 1–2 cell stage
embryos of 12xSBE line with a plasmid containing the smad3b
sequence in frame with YFP sequence under the control of heat-
shock 70 promoter (hsp70). For smad7, the Tg(12xSBE:nls-mCherry)
ia15 line has been crossed with the Tg(hsp70:smad7-YFP) line. In
both cases, heat-shock was performed 3 times for 300 at 37 1C
every 12 hours starting from 24 hpf. Larvae were observed at the
confocal microscope 2 h after the third heat-shock.
Confocal analysis and colocalization measurements
Fluorescence was visualized at the Leica M165FC dissecting
microscope and then at the Nikon C2 H600L confocal microscope.
For in vivo analyses embryos and larvae were anesthetised with
tricaine and mounted in 0.7% low melting agarose gel. EGFP and
mCherry ﬂuorescence was visualized by using 488 and 561 nm
lasers, respectively, through 20x and 40x immersion objectives
(Nikon). All images were analyzed with Nikon software. Colocali-
zation was measured with Volocity 6.0 software. Statistical ana-
lyses were carried out with Prism GraphPad software. For analysis
of Smad3/TGFβ signal dynamics at 24 hpf, we mated Tg(12xSBE:
nls-mCherry)ia15 with the following transgenics: Tg(ngn1:GFP)sb1,
Tg(2.4 kb neurod:EGFP), Tg(mnx1:GFP)ml2. Between 15 and
24 hpf somites are formed at a rate of 2/h; thus, each somite
corresponds to a point in time expressed in hours of development.
Colocalization was expressed as Manders' coefﬁcient (Manders
et al., 1993; Dunn et al., 2011) and refers to mCherry/TGFβ. It was
measured in 4 sequential somites pairs (tail to head), and
6 tails were analyzed. Resulting values were plotted as a function
of somite/time (as hours of development). Manders' coefﬁcients
M1 and M2 are deﬁned as the proportion of intensity in Red
channel (TGFβ reporter) that coincide with intensity in the
Green (progenitor/precursor) channel (Manders et al., 1993).
Mander's coefﬁcients were used in place of Pearsons' because
M1 and M2 are less dependent on the intensity ratios between
channels and the intensity is considered as amount of ﬂuores-
cence, not as volume occupied by each channel. Therefore,
if one channel occupies a larger volume than the other (as
registered with TGFβ/mCherry and the three neural markers/
GFP), Manders' coefﬁcients can better measure any correlation
between them. For each type of experiment, a number of embryos
or larvae (from 15 to in excess of 100) were sampled and the
correlation between treatment and phenotype quantiﬁed. Results
of quantiﬁcation are presented in Supplemental Table S1. For all
the experiments of quantiﬁcation, we used heterozygous embryos
and larvae derived from oucrossing a transgenic male of the ia15
or ia16 lines.
Whole-mount immunohistochemistry
Embryos and larvae were ﬁxed in 4% PFA/PBS overnight
and then stored in 0.15% TritonX-100 in PBS (PBTr) at 4 1C. Tissues
were permeated through incubation with 10 mg/ml Proteinase K at
room temperature. Blocking was done with 4% BSA in PBTr for 2 h
at room temperature. Specimens were immunostained with anti-
bodies anti-phospho-Smad3 (ab52903, Abcam, Cambridge, UK),
anti-GFP (A10262, Lifetechnology, CA) and anti-phospho-histone
H3 (06-570, Millipore, MA), according to standard procedures. The
following secondary antibodies were used: Goat Anti-Rabbit IgG,
AP conjugate (Secondary Antibody Millipore™, 112448, Upstate™,
MA), Alexa Fluors 488 Goat Anti-Chicken IgG (HþL) Antibody
(A1-1039, Lifetechnology, CA) and Polyclonal Swine Anti-Rabbit
Immunoglobulins/TRITC (R0156, DakoCytomation, Glostrup, Den-
mark). Cell proliferation observed through IHC for pH3 and EdU
assay was measured with Volocity 6.0 software and reported in
supplemental tables and graphs. Statistical analyses were per-
formed with GraphPad Prism software.
Results
Generation of a Smad3-dependent zebraﬁsh reporter line
A Smad3-binding sequence, known to be regulated by TGFβ
signaling, was identiﬁed in the regulatory region of human PAI-1
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gene (Dennler et al., 1998). 12 repeats of this speciﬁc sequence,
namely CAGA box, were cloned together with major late promoter
Adenovirus (MLP) into a Gateway 50 entry vector. These sequences
were used to control the expression of ﬂuorescent reporter genes,
such as GFP and nls-mCherry. To prepare transgenic reporter lines
Tg(12xSBE:EGFP)ia16 and Tg(12xSBE:nlsmCherry)ia15, a Tol2 vector
containing TGFβ-responsive sequences was co-injected together
with Tol2 Transposase mRNA into one-cell stage wild-type
embryos. Mosaic transgenic ﬁsh were selected at roughly 24 h
post-fertilization (hpf) and raised to the adult stage for screening.
Positive founders were selected for the ﬂuorescence level of their
offspring in areas of known Smad3 activity (Fig. 1A) and by
checking reporter expression to SB-431542, a known Alk4- and
Alk5-inhibitor (Fig. 1B). It can be observed that at 15 hpf, GFP
ﬂuorescence is weak or undetectable but its mRNA staining is
strong in the posterior trunk, while at 26 hpf ﬂuorescence of GFP
in the tail is stronger than its mRNA: this is because GFP
expression follows its mRNA translation and is more stable.
Founders for EGFP and nls-mCherry have been compared (Fig. S1
and Table 2), selected and used to follow in vivo Smad3-mediated
TGFβ signaling. Notably, while a wide GFP expression is visible
early after fertilization in the offspring of Tg(12xSBE:EGFP)ia16
females due to a maternal effect (Fig. S1), by mating heterozygous
Tg(12xSBE:EGFP)ia16 males with a wild type females we obtain
50% of GFPþ embryos, without relevant differences in ﬂuores-
cence among them (Fig. S1 and Table 3).
Pharmacological, genetic and molecular analyses show that Tg
(12xSBE:EGFP)ia16 and Tg(12xSBE:nlsmCherry)ia15 are TGFβ/Smad3
reporters
We used different pharmacological and genetic approaches to
demonstrate the speciﬁcity of Smad3-responsive transgenic lines.
Both Tg(12xSBE:EGFP)ia16 and Tg(12xSBE:nlsmCherry)ia15, also
called 12xSBE lines, were tested at 24 hpf with an Alk4- and Alk5-
inhibitor, SB-431542, and a more speciﬁc Alk5-inhibitor, LY364947
(not shown). After two days of treatment, the ﬂuorescent reporter
expression was drastically reduced compared to the control at the
same stage of development (Fig. 1B). Moreover, RNA in situ
hybridization shows a consistent reduction of reporter transcripts
after 8 h of incubation with SB-431542 in Tg(12xSBE:EGFP)ia16
embryos treated at 24 hpf (Fig. 1C).
For genetic validation, the Tg(12xSBE:EGFP)ia16 line was
crossed with one-eyed-pinhead (oep) and chordin (dino) mutant
lines (Fig. S2). One-eyed-pinhead (TDGF1 or CFC1) is a cofactor of
Nodal signaling, a subset of the TGFβ family, involved in mesen-
doderm speciﬁcation, left–right axis speciﬁcation and anterior-
posterior axis orientation. In absence of zygotic oep, TGFβ-
responsive line lacked GFP expression in cardiac mesoderm,
underlying the role of oep-mediated TGFβ signaling in mesendo-
derm speciﬁcation (Fig. S2B0″). On the other hand, the reporter
expression was unchanged in the spinal cord (Fig. S2A0–B0), the
formation of which does not require Nodal signaling (Jia et al.,
2009).
Chordin is a major Bmp2/4 antagonist, expressed in zebraﬁsh
by shield stage. Both BMP and TGFβ1/2/3 belong to the TGFβ
superfamily and have a similar transduction pathway. However,
they require speciﬁc receptors and receptor-activated Smads. BMP
and TGFβ have opposite roles in neural induction (negative and
positive effects, respectively) (Schmidt et al., 2013). To evaluate the
speciﬁcity of 12XSBE transgenic lines for TGFβ1/2/3-Smad2/3,
reporter expression was evaluated in embryos missing the activity
of chordin. Despite the obvious morphological changes due to axis
speciﬁcation disruption, we did not observe changes in ﬂuores-
cence in the spinal cord of the mutants (Fig. S2A0–C0). Finally,
treatments of 12XSBE embryos with LDN193189, an Alk2/3
inhibitor (Cuny et al., 2008), show no effect on the ﬂuorescence
of the reporter (Fig. S2D–E). This conﬁrms the speciﬁcity of the
reporter line for Smad3 rather than Smad1/5/8 and also conﬁrms
the idea of independent actions of TGFβ1/2/3 and BMP signaling
on spinal cord development (Jia et al., 2009).
The 12xSBE lines were created using elements recognized by
Smad3. To test their level of response and speciﬁcity, 1–2 cell-stage
embryos were injected with morpholinos for smad2/3a/3b/4 and
their ﬂuorescence was checked at 24 hpf (Fig. 2A and Table 3). The
morpholinos for smad2/3a/3b have been already tested and pre-
viously validated and were able to induce different degrees of
neural degeneration and growth retardation; morphant embryos
fail to form ﬂoor plate, have eye malformations and bent notochord
(Jia et al., 2008). A further validation for these morpholinos was
performed through RT-PCR (MO-smad2) or immunohistochemistry
(MO-smad3a and 3b) (Fig. S3). When injected in the 12xSBE lines,
MO-smad2 had a partial effect on reporter activity in the neural
tube, when given a high dose of morpholinos (Fig. 2 and Table 4).
On the other hand, ﬂuorescence was drastically reduced with MO-
smad3b and completely abolished with MO-smad3a, demonstrating
a strong speciﬁcity of the 12xSBE transgenic lines for Smad3 activity
(Fig. 2A). Both zebraﬁsh smad3 isoforms, 3a and 3b, are expressed in
the tail region (Pogoda and Meyer, 2002; Hsu et al., 2011) and the
efﬁcacy of MO-smad3a might be due to either a higher activity of
the smad3a morpholino or to a higher expression/function of this
gene. In all smad3a, smad3b and smad2 morphants, no ﬂuorescence
was detected in the cardiac mesoderm. In fact these genes are
known to play an important role in mesoderm speciﬁcation and
outﬂow tract formation (Jia et al., 2008; Zhou et al., 2011). To test if
smad2 can cooperate with smad3 for the reporter expression, the
lowest effective dosage of both morpholinos was coinjected in
fertilized eggs of the Tg(12xSBE:EGFP)ia16 line. In smad2/smad3a
coinjected embryos half the effect in the number of GFP positive
embryos was obtained, when comparing the phenotype with
embryos injected with a double dosage of MO-smad3a (Fig. S4
and Table S4). Furthermore, MO-smad3a injection at non teratogenic
dose can abolish GFP expression, while in smad2 morphants with a
severe phenotype the reporter expression is only slightly affected
(Fig. 2A). Thus, it can be assumed that Smad2 does not cooperate
with Smad3a in 12XSBE reporter activation.
Smad4 is a common permissive factor for both TGFβ1/2/3 and
BMP cascades, necessary for activation of all R-Smad-mediated
signaling. Four different smad4 morpholinos were designed and
tested for their ability to abolish GFP expression in the TGFβ1/2/3-
responsive line (not shown). MO3-smad4, speciﬁc for a splicing-
donor site, was the most efﬁcient and was used for knock down
injections (Fig. 2A). This morpholino was tested through both RT-
PCR (Fig. S3) and injection in BMP-responsive line (not shown).
smad4morphants showed the most severe growth retardation, eye
malformation and notochord defects when compared with smad2/
3a/3b-morphants. The severe phenotype is possibly due to the
pleiotropic permissive functions of Smad4.
To test the speciﬁcity of the Tg(12xSBE:EGFP)ia16 line for each
TGFβ-associated transcription factor, smad2, 3a, 3b and 4 mRNAs
were injected in fertilized eggs and GFP expression checked at
24 hpf under the epiﬂuorescent microscope (Figs. S5 and S6).
smads mRNAs injection resulted in different abnormalities in the
embryos; smad2mRNA injections caused eye and head reductions,
enlargement of yolk extension and caudal aedema; smad3a over-
expression led to tail bending. smad3b mRNA injection seemed to
be more deleterious than smad3a: the eyes and head are
smaller and the notochord bent. Coinjection of smad3a and 3b
created a third phenotype with mixed defects: the anterior region
normal, in the posterior a bent notochord and absence of yolk
extension. GFP levels were unchanged by overexpressing smad2,
3a and 4. In contrast, injection of smad3b mRNA and, even more,
A. Casari et al. / Developmental Biology 396 (2014) 81–93 85
the coinjection of smad3a and 3b mRNAs, increased GFP expres-
sion in tail and heart mesoderm and, notably, resulted in a strong
ectopic expression of the reporter in the notochord of coinjected
embryos (Figs. S5 and S6). Both normal (Fig. S5) and malformed
(Fig. S6) embryos were used to draw these conclusions.
To demonstrate that reporter expression correlates with Smad3
activation at an intracellular level, expression of phosphorylated
Smad3 was checked by immunohistochemistry (Fig. S7) at different
stages (50% epiboly, tail bud, 13, 15, 24, 36 and 48 hpf) and compared
to GFP expression in the same developmental stages of the Tg
(12xSBE:EGFP)ia16 line. Although no ﬂuorescence was observed ear-
lier than 13 hpf, later stages show a correlated pattern of reporter/
phospho-Smad3 expression in tail and heart mesoderm, spinal cord,
eyes, hindbrain, cloaca and ﬁn buds. It can be supposed that a certain
level of Smad3 is required for reporter activation while lower levels
are not sufﬁcient to be detected with the Tg(12xSBE:EGFP)ia16 line.
Furthermore, immunohistochemistry for phospho-Smad3 was per-
formed in 24 hpf embryos and 48 hpf larvae of the Tg(12xSBE:EGFP)
Fig. 2. Responsiveness of Tg(12xSBE:EGFP)ia16 line to Smad3. (A) Brightﬁeld and ﬂuorescent lateral images of smad2-, smad3a-, smad3b- and smad4-morphants at 24 hpf at
the epiﬂuorescent microscope, left to right. smad2, 3a and 3b morphants show a similar phenotype: anterior truncation, a curved shortened body axis, absence of ﬂoorplate
and an enlarged intermediate cell mass. smad4morphants exhibit the most severe phenotype: similar characteristics of the other morphants accompanied with a shortened
body due to BMP inhibition. Reporter expression is completely inhibited in smad4 and 3amorphants and strongly reduced in smad3bmorphants. smad2morphants lack GFP
expression in the cardiac mesoderm and telencephalon (white arrow head) and display a mild reduction in the neural tube. (B) Phosphorylated-Smad3 correlates to reporter
expression in the 12xSBE line. Confocal lateral views of double ﬂuorescent immunohistochemistry for GFP (green) and phosphorylated Smad3 (red) on embryo and larva tails
at 24 and 48 hpf; zoomed views on the edge of the tail of a 24 hpf embryo. Arrowheads point to GFP/p-Smad3 double positive cells.
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ia16 line (Fig. 2B): at both stages Smad3 activation was revealed in
neural tube and tail mesoderm, with a decreasing rostro-caudal
gradient, as seen in the transgenic lines. Reporter-expressing cells
colocalized with phospho-Smad3 positive cells (Fig. 2B). In particular,
at 24 hpf stage, it can be observed that coherently with the
mechanistic sequence (Smad3 is phosphorylated, it enters the
nucleus and activates transcription/translation of GFP), cells in which
the phospho-Smad3 colocalizes with GFP are older than (rostral to)
cells in which the phospho-Smad3 (in red) has just entered the
nucleus, while they are younger than (caudal to) cells in which
the phospho-Smad3 concentration has already decreased, leaving
the reporter activated.
To further demonstrate the speciﬁcity of the 12xSBE lines, we
induced the overexpression of either smad7 or smad3b in 24 hpf
embryos (Fig. 3). SMAD7 is an inhibitory SMAD able to block
SMAD3-mediated TGFβ signaling by inhibiting phosphorylation of
type I receptor, recruiting SMURF1 and 2 and leading to protea-
somal degradation of ligand-receptor complexes (Yan et al., 2009).
The Tg(12xSBE:nlsmCherry)ia15 line was crossed with a transgenic
line expressing smad7 and YFP coding sequences both under the
control of the hsp70 regulatory region. Heat-shocked larvae
analyzed at the confocal microscope revealed a strong activation
of YFP and a dramatic reduction of mCherry in the entire embryo
(Fig. 3A–A″). Similarly, 1–2 cell stage embryos of the Tg(12xSBE:
nlsmCherry)ia15 line were injected with a plasmid containing
smad3b and YFP coding sequences under the control of the hsp70
regulatory region and the resulting embryos heat shocked at the
24 hpf stage. As shown in Fig. 3, only heat-shocked embryos
showed expression of the YFP. As a plasmid was injected the
expression was mosaic. Notably, 12xSBE reporter expression levels
were signiﬁcantly increased in cells co-expressing YFP (i.e., muscle
in the trunk) meaning that smad3 driven by the hsp70 promoter
causes cell-speciﬁc reporter activation (Fig. 3C–C″).
In conclusion, pharmacological, mutants, morpholinos and
molecular analyses show that the zebraﬁsh 12xSBE lines are bona
ﬁde TGFβ/Smad3 responsive, in vivo.
During the ﬁrst month of development Smad3-mediated TGFβ
signaling is mainly observed in the nervous system
Then, we decided to analyze the spatio-temporal ﬂuorescent
activity of 12xSBE lines. While a wide GFP expression is visible
early after fertilization in the offspring of Tg(12xSBE:EGFP)ia16
female carriers due to a maternal effect, a more speciﬁc ﬂuores-
cence with zygotic origin appears at late somitogenesis (15 hpf) in
the tail (both mesoderm and neural tube) and cardiac mesoderm
region (Fig. 1A). At 26 hpf ﬂuorescence is also visible in the
telencephalic region. At 48 hpf reporter expression gradually
extends to the entire neural tube, moving in a gradient that
decreases from the tail (Fig. 1A). Tg(12xSBE:EGFP)ia16 and Tg
(12xSBE:nlsmCherry)ia15 lines show a similar ﬂuorescence
expression pattern (Figs. 1 and S1). Differences can be seen in
the exact time of expression in speciﬁc tissues due to the
different accumulation/degradation dynamics of the two ﬂuores-
cent proteins.
Outside of the central nervous system (CNS), ﬂuorescence is
distinguishable in the retina, lens and olfactory epithelium
(Fig. S8D–E). Reporter-expressing cells are found in cardiac meso-
derm at 24 hpf, where they give rise to the outﬂow tract (Zhou
et al., 2011) (Fig. S8A–B0). In the heart region the reporter is still
expressed at 3–4 dpf in the outﬂow tract and some cells distrib-
uted in the dorsal aorta (Fig. S8C–C0). Some ﬂuorescent cells are
also distinguishable in the jaws at 4 dpf (Fig. S8F–F0), while a weak
GFP expression is visible in pectoral ﬁns (Fig. S8G) and cloaca. Fins,
cloaca and outﬂow tract are even more appreciable in Tg(12xSBE:
nlsmCherry)ia15. In the tail and cardiac region, the reporter
expression is also found in mesodermal cells. In fact, Smad3
signaling is known to be involved in mesoderm speciﬁcation (Jia
et al., 2008).
At about one month post-fertilization, ﬂuorescence decreases
in the entire central nervous system. It is still expressed at a low
level in the ventral part of the CNS, particularly in the telence-
phalic region. At this stage, some muscle ﬁbers of the median
musculature start expressing the reporter gene (Fig. S8H). Indeed,
the role of TGFb signaling in the control of muscle development is
well-known (Ge et al., 2012; Hsu et al., 2011).
In adult ﬁsh, EGFP expression is localized at the edge of each
vertebra and in the lens, while in Tg(12xSBE:nlsmCherry)ia15
ﬂuorescence is detectable in the ventricular zone of the brain
and telencephalic region (data not shown).
A more detailed observation of the Tg(12xSBE:EGFP)ia16 line
with the confocal microscope gives a better understanding of brain
Fig. 3. Tg(12xSBE:nls-mCherry)ia15 line is responsive to smad7 and smad3b over-
expression. A–C″, confocal lateral views (Z-stacks) of 48 hpf double transgenic
larvae, Tg(12xSBE:nls-mCherry)ia15/(hs-Smad7/YFP) or (hs-Smad7/YFP). As shown in
the schematic 48 hpf larva, three areas have been analyzed: head, trunk and tail.
Each picture shows the merge of YFP (green) and mCherry (red) and it is
accompanied by a small ﬁgure (white square) representing mCherry ﬂuorescence
following the heat-shock. (A–A″) Confocal lateral views of 48 hpf double transgenic
larvae, Tg(12xSBE:nls-mCherry)ia15/(hs-Smad7/YFP). Heat-shock causes a downre-
gulation of the 12xSBE reporter (in red) and ubiquitous production of YFP (in
green). (B–B″) Confocal lateral images of 48 hpf non-heat-shocked double trans-
genic larvae, Tg(12xSBE:nls-mCherry)ia15/(hs-smad7/YFP) and Tg(12xSBE:nls-
mCherry)ia15/(hs-smad3b/YFP). Only non-heat-shocked Tg(12xSBE:nls-mCherry)
ia15/(hs-smad7/YFP) is shown as a control. (C–C″) Confocal lateral views of 48 hpf
heat-shocked double transgenic larvae, Tg(12xSBE:nls-mCherry)ia15/(hs-smad3b/
YFP). The heat-shock leads to a smad3b overexpression conﬁrmed by mosaic
production of YFP. White arrow heads show ectopic expression in the head, trunk
muscle and tail. (D–D″) Zoomed views (single planes) of Tg(12xSBE:nls-mCherry)
ia15/(hs-smad3b/YFP) highlight the ectopic reporter expression induced by smad3b
overexpression. Scale bar is 100 mm in A–C″; 20 mm in D–D″. Scale bar is 100 mm in
A–B0 , E–F0 , G, H; 50 mm in C0–C″; and 20 mm in G0 , H0 .
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tissues activating Smad3 mediated TGFβ signaling. Anteriorly, the
reporter is activated in the forebrain (subpallium and preoptic
region) in the midbrain (tegumentum and tectum opticum), cere-
bellar plate, while in the hindbrain it is mainly expressed in the
medulla oblongata, as seen in Fig. 4 and supplemental movie
1 obtained with the aid of Vibe-Z analyses (Ronneberger et al.,
2012). In the neural tube, ﬂuorescent cells occupy ventricular and
transition zones, where neuronal precursors proliferate and neu-
roblasts start their differentiation, respectively (Fig. 4).
Supplementary material related to this article can be found
online at http://dx.doi.org/10.1016/j.ydbio.2014.09.025.
Smad3 mediated TGFβ signaling is activated in neuronal precursors
Smad3 activation is known to have a neurotrophic effect on
DOPAminergic neurons (Krieglstein et al., 2002; Tapia-Gonzalez
et al., 2011), motor neurons (Ho et al., 2000) and interneurons
(Garcia-Campmany and Marti, 2007) where it seems to be involved
in axonal growth (motor neurons), differentiation process (interneur-
ons) and positioning of differentiating neurons in the neural tube.
Thus, supported by the pattern expression of 12xSBE lines, we
focused our attention to understanding the nature of cells in which
the reporter is active. For this purpose, Tg(12xSBE:nlsmCherry)ia15
line was crossed with different transgenic lines expressing GFP
under the control of promoters speciﬁc for neural populations,
thus labeling different populations of progenitor, precursor and
committed neural cells (ngn1, neuroD, mnx1). The reporter expres-
sion of each double transgenic was followed during the ﬁrst week
of development at the confocal microscope. The highest level of
colocalization is seen with neuroD (Fig. S9) while no colocalization
can be observed with mnx1 (Fig. S9). On the other hand, ngn1, a
marker labeling both small populations of progenitors and some
differentiated neurons, reveals a signiﬁcant degree of colocaliza-
tion with the Smad3 reporter at the very tip of the tail, where
neuronal progenitors develop (Fig. S9). To examine the dynamics
of cells activating Smad3 mediated TGFβ signaling, we measured
colocalization in the tail of 24 hpf double transgenic embryos. Our
logic was thus: between 15 and 24 hpf stages, somites form at a
constant rate. Therefore, the tail region was divided into pairs of
somites and colocalization (expressed as Manders'coefﬁcient
referred to TGFβ on mCherry ﬂuorescence) was evaluated in four
regions starting from the edge of the tail toward the trunk (Fig. 5).
The region of caudal somites is the earliest forming and the ﬁrst
activating Smad3 signaling in the neural tube. In our graphs, the
colocalization in the region of the ﬁrst pair of somites corresponds
to the starting point of expression of TGFβ1/2/3 signaling (0 h) and
has been plotted as a function of somite/time. As shown on the
graphs (Fig. 5), at the time of its activation (time 0) TGFβ1/2/3
signaling has its highest colocalization with cells expressing ngn1,
a marker typical of proliferating neural progenitors of the region
(Korzh et al., 1998). By moving anteriorly, there is a progressive
reduction of mCherryþ /ngn1þ cells. Conversely, the number of
mCherryþ /neuroDþ cells increases when moving anteriorly
(Fig. 5), and it is worth mentioning that neuroD is a good marker
of all neuronal precursors (Korzh et al., 1998). In mnx1-expressing
cells (differentiating motor neurons), mCherry expression remains
very low in all four areas examined (Fig. 5). Notably, similar trends
were observed when levels of colocalization of mCherry (TGFβ)
Fig. 4. Reporter expression during early larval development: central nervous system. Confocal images of brain and neural tube of Tg(12xSBE:EGFP)ia16 larvae at different
stages of development. (A) Dorsal view of the brain of a 4 dpf larva (Z-stack). GFP is expressed in the hindbrain, diencephalon and telencephalon. (B) Zoomed lateral views of
the hindbrain in a larva at 3 dpf (single plane). (C) Dorsal views of GFP-expressing cells in the subpallium of a 10 dpf larva (Z-stack). (C0) Zoomed dorsal view of GFPþ cells in
the subpallium (Z-stack). (D) Lateral view of the neural tube in a 72 hpf larva (Z-stack). (D0–D″), 3D-reconstruction of the neural tube of D at the level of the dashed line
(D0 , lateral and, D″, sagittal view). Reporter expression is mainly localized around the central canal (cc). (E) Lateral view of an eye in a 36 hpf larva (Z-stack). (F–H) Single
planes of Tg(12xSBE:EGFP)ia16 brain at 72 hpf. Images have been obtained with VibeZ software. h¼hindbrain, sb¼subpallium, cc¼central canal, pr¼proliferating retina,
le¼ lens, hy¼hypothalamus, to¼tectum opticum, mo¼medulla oblongata. Scale bar is 100 mm in A, D; 50 mm in C; 20 mm in E; and 10 mm in B, C0 , D0–D″.
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and GFP (neuronal markers) at days 1, 2, 3 and 4 of development
were compared (Fig. S9), conﬁrming TGFβ is progressively turned
on in the progenitor/precursor switch.
EdU assay shows that Smad3 mediated TGFβ signaling is a
postmitotic signal
Once established that Smad3 mediated TGFβ signaling in the CNS
is localized in committed neural precursors, we wanted to understand
its role in development of neural cell lineage. Functional experiments
with neuronal transgenic lines show that smad3 activation is impor-
tant for neurogenesis (Garcia-Campmany and Marti, 2007). To check
whether smad3 activation is involved in control of mitosis, we tested
how the cell proliferation marker phospho-histone-3 (pH3) was
affected in MO-smad3a injected embryos analyzed at 24 hpf or in
larvae treated with LY364947 from 24 to 48 hpf. Results show that
reporter signal (green) and pH3 immunoﬂuorescence (red) do not
colocalize (Figs. 6 and S4). Notably, blocking Alk4/5-Smad3 signaling
leads to a signiﬁcant increase of proliferating cells (Figs. 6 and S10). To
further conﬁrm this Smad3 mediated TGFβ effect, an EdU proliferation
assay was performed on 20 hpf embryos treated with LY364947 at
12 hpf. Results show a strong increase of proliferation (Figs. 6 and S10).
Thus, at early stages of development Alk4/5-Smad3 signaling seems to
play an important role in regulating the cell cycle. We veriﬁed the
function of Smad3 mediated TGFβ signaling on neural progenitor cell
cycle by EdU proliferation assay on Tg(12xSBE:EGFP)ia16 embryos at
24 hpf (Fig. 6): embryos treated with EdU were ﬁxed and stained after
a chase of either 2 or 8 h. Cells stained after a chase of 2 h are roughly
in S/G2 phase, while cells stained 8 h after the EdU pulse are in early
G1 phase. Analysis of colocalization of GFP and EdU shows that
proliferating cells (2 h in chase) do not express the reporter, while
postmitotic cells (8 h in chase) do. In other words, at 24 hpf, the
majority of cells with activated Smad3 are non proliferating but have
just undergone mitosis, letting us conclude that Alk4/5-Smad3 in
central nervous system development is mainly a postmitotic signal.
To conﬁrm the hypothesis that Smad3 mediated TGFβ signaling
blocks proliferation of some progenitor cells allowing their differ-
entiation, smad3amorpholino was injected in 1–2 cell stage embryos
of the transgenic lines Tg(ngn1:GFP)sb1, Tg(2.4 kb neurod:EGFP) and
Tg(mnx1:GFP)ml2 (Fig. 7). At 24 hpf smad3a morphant embryos
show a decrease in GFP expression in motor neurons (mnx1), with
defects in axon development and soma position in the neural tube
(Fig. 7). The reduction of these cells in embryos treated with
morpholino against smad3a is accompanied by a loss of their
precursors as revealed by neuroD as well as an increase of neural
progenitors revealed in the Tg(ngn1:GFP)sb1 line, particularly at the
tail tip (Fig. 7 and Supplemental Table S5). The 12xSBE ﬁsh lines were
also treated with Alk5-inhibitor LY364947 at 2 hpf and 24 hpf (Figs. 7
and S11). As shown in the ﬁgure, the results of these chemical
treatments agree with those of the smad3a morpholino: an increase
of ngn1þ at the tail end together with a concomitant decrease of
neuroDþ and mnx1þ cells. In conclusion, both approaches gave
Fig. 5. Smad3 reporter is expressed in progenitors and precursors. Confocal lateral view of tail of double transgenic embryos obtained crossing Tg(12xSBE:nls-mCherry)ia15 to
the following transgenics: Tg(ngn1:GFP)sb1, Tg(2.4 kb neurod:EGFP) and Tg(mnx1:GFP)ml2. Colocalization was measured in the tail of 24 hpf double transgenic embryos
with the following method. From 15 to 24 hpf, two somites are formed each hour. Tail region was divided in pairs of somites and colocalization (Manders'coefﬁcient referred
to TGFβ-mCherry ﬂuorescence) evaluated in four of them (as white dotted circles) starting from the edge of the tail toward the trunk. For each time point, the average value
of Manders' coefﬁcient has been calculated from six double transgenic embryos and plotted on as a function of the corresponding hour of development (hd). Second column:
magniﬁcation of speciﬁc regions (single plane). Third column: double ﬂuorescent cells are shownwith arrowheads (single plane). Developmental time of each magniﬁcation
is indicated inside the panel. Fourth column: graphical representation of quantitative analysis as Mander's coefﬁcients of the four developmental points; n¼6 per each point.
Scale bar is 100 mm in the ﬁrst column, 20 mm in the second column, 10 mm in the last column.
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similar results on the role of Alk4/5-Smad3 mediated TGFβ signaling
in controlling the progenitor/precursor switch.
Discussion
Through this work we have developed zebraﬁsh transgenic line
12xSBE, responsive to Smad3 mediated TGFβ1/2/3-Alk4/5 signaling.
Through pharmacological, genetic and molecular characterization
we have seen that this transgenic line reports Smad3 activity and
can be used to follow the TGFβ1/2/3 branch of signaling in vivo, at
single cell resolution.
Treatment with chemical Alk4- and Alk5-inhibitors (SB-431542 and
LY-364947), which blocks phosphorylation of Smad3 by TGFβ1/2/3
type-I receptors, inhibits reporter expression: the transcription
of the reporter gene is abolished within 8 h of treatment with SB-
431542 (Fig. 1C), while ﬂuorescence level is reduced after 1 day of
treatment (data not shown) and completely blocked after 2 days
(Fig. 1B). Conversely, treatments with LDN193189 (a speciﬁc Alk2,3
inhibitor) left the ﬂuorescence unchanged (Fig. S2). Moreover,
immunohistochemistry for phospho-Smad3 has demonstrated that
this transcription factor is present during gastrulation, though the
quantity is insufﬁcient to activate reporter transcription and transla-
tion of the Tg(12xSBE:EGFP)ia16 line at detectable ﬂuorescence levels
(Fig. S7). At the tail bud neither phospho-Smad3 nor reporter
expressions are appreciable (Fig. S7). At 13 hpf phospho-Smad3 and
GFP are both expressed in the mesoderm (cardiac and tail) and spinal
cord (Fig. S7). At the same stage, while phospho-Smad3 is clearly
Fig. 6. Smad3/TGFβ signaling is mainly active in post-mitotic cells. (A–B0) Confocal lateral views of immunoﬂuorescence for GFP (green) and phospho-Histone3 (pH3, red) on
Tg(12xSBE:EGFP)ia16 embryos injected at 1–2 cell stage either with the control (A), or smad3a-morpholino (B). For each confocal picture (Z-stack), a small brightﬁeld view of
a morphant embryo shows which area is displayed (red dashed line). (C–D) Confocal lateral views of immunoﬂuorescence for GFP (green) and pH3 (red) on 2 dpf larva of Tg
(12xSBE:EGFP)ia16 line treated with either DMSO (C) or LY364947 (D) at 24hpf. For each confocal picture (Z-stack), a small brightﬁeld view of a 48 hpf larva shows which area
is displayed (red dashed line). (C0 and C″) Confocal zoomed views (single plane) of hindbrain and tail, respectively, of immunoﬂuorescence for GFP (green) and pH3 (red) on
DMSO-treated larva of the 12xSBE line. (E–F) Confocal lateral views of the head (E, F) or tail (E0 , F0) regions after EdU labeling on 20 hpf embryos treated at 12 hpf either with
DMSO (E, E0) or LY364947 (F, F0). For each confocal picture (Z-stack), a small brightﬁeld view of a morphant embryo shows which area is displayed (red dashed line). (G, H)
confocal lateral images (Z-stack) of pulse and chase EdU assay on 24 hpf embryos of Tg(12xSBE:EGFP)ia16 line. Embryos have been ﬁxed after a chase of either 2 (G–G0) or 8
(H–H0) hours (hrs) and immunostained for EdU (red) and GFP (green). EdUþ cells ﬁxed after 2 h are roughly in S/G2 phase, while EdUþ cells ﬁxed after 8 h of chase are post-
mitotic. (G0 , H0) Zoomed view (single plane) of Tg(12xSBE:EGFP)ia16 tail after 2 or 8 h chase. Scale bar is 100 mm in A–B0 , E–F0 , G, H; 50 mm in C0–C″; 20 mm in G0 , H0 .
Quantiﬁcation is presented in Supplemental Table S4.
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visible in the eye, the reporter is not. This difference could be
explained in many ways: an immunohistochemistry artefact or
phospho-Smad3 levels are not sufﬁcient to induce reporter expres-
sion. It is possible Smad4 is missing or a phospho-Smad3 corepressor
is inhibiting transcription; in fact the lens and retina start to be GFP
positive from 24–26 hpf. Similar restrictions could explain the
presence of phospho-Smad3þcells in the entire tail mesoderm,
while the reporter is limited to the tail edge. The speciﬁcity of the
reporter is also conﬁrmed by smadsmRNA injection in the Tg(12xSBE:
EGFP)ia16 line (Figs. S5 and S6). smad3b mRNA and smad3a and 3b
mRNAs together can ectopically activate the reporter. Notably, this
can happen only if embryos are injected with Smad3 mRNA, while
Smad4 and 2 have no effect in reporter activation. Through ﬂuor-
escent immunohistochemistry we have demonstrated reporter
expression follows the nuclear localization of phospho-Smad3
(Fig. 2B). The partial colocalization of GFP and phospho-Smad3 is
expected, as it takes time for phospho-Smad3 expression to over-
come both a threshold level of the transcription factor and the time
to have an appreciable transcription and translation of the reporter.
Genetic and molecular approaches gave us more details about
reporter expression in the transgenic line. GFP expression of Tg
(12xSBE:EGFP)ia16 line has been tested in two different genetic
backgrounds: one-eyed-pinhead (oep) and chordin (dino) mutants.
One-eyed-pinhead (Oep) is an EGF-CFC protein and cofactor
necessary for Nodal/Activin branch of TGFβ signaling, a cascade
culminating with the activation of Smad2 rather than Smad3 (Fei
et al., 2010). In oep mutants of the transgenic line, GFP expression
was absent in the cardiac mesoderm (Fig. S2); no signiﬁcant
changes in expression levels were observed in the neural tube,
where Smad3 activity seems to be independent from Nodal
ligands. Although it was demonstrated that Nodal signaling is
involved in anterior neural tube closure, neuroectoderm speciﬁca-
tion (Aquilina-Beck et al., 2007) and hypothalamus development
(Rohr et al., 2001), it acts mainly through Smad2 (Fei et al., 2010)
and seems dispensable to spinal cord induction (Jia et al., 2009).
As BMP and TGFβ1/2/3 show a similar transduction pathway
but different types of receptors, R-Smads and their relative
target sequence in the genome, we tested the effects of BMP
activation on Smad3-mediated reporter expression by analyzing
mutants of chordin, a BMP2/4 antagonist. It was demonstrated
that Smad2/3 upregulate BMP inhibitors, such as chordin, BMP
inhibition is important for neural induction (Jia et al., 2009;
Cruz et al., 2010) and levels of GFP expression in the neural tube
of dino mutants compare with that of sibs, conﬁrming the
speciﬁcity of 12xSBE transgenic line for TGFβ1/2/3-associated
R-Smads (Fig. S2).
Morpholino-mediated knock-down of R-Smads and Co-Smad
conﬁrmed the speciﬁcity of both Tg(12xSBE:EGFP)ia16 and
Tg(12xSBE:nlsmCherry)ia15 lines for Smad3/4. Concerning R-
Smads morphants, the transgenic lines seemed to be sensitive to
both zebraﬁsh isoforms of smad3: smad3a and smad3b. When
embryos were injected with smad3a morpholino, they failed to
express both EGFP and mCherry (Fig. 2A and not shown). Knock-
down of smad3b strongly inhibited reporter expression, which was
limited to the tip of the tail. We envisage two possible explana-
tions for these results: (1) a higher efﬁcacy of the smad3a
morpholino with respect to the smad3b one; (2) different levels
of genetic additivity for the two loci allow smad3a to partially
compensate for smad3b absence in the spinal cord, but not
viceversa.
Though the transgenic lines were designed with Smad3-
responsive sequence (Dennler et al., 1998), the injection of smad2
morpholino inhibited reporter expression in the cardiac meso-
derm and interfered with ﬂuorescence in the tail region (Figs. 2A
and S3). In contrast to what is seen for SMAD2 and 3 in the chicken
neural tube (Lan, 2011) (Miguez et al., 2013), only high doses of
Fig. 7. In vivo blocking of Smad3/TGFβ signaling impairs neuronal differentiation during early embryonic development. Confocal Z-stack tail images of 24 hpf transgenic
embryos expressing GFP under control of neuronal promoter: ngn1, neuroD, and mnx1. Embryos were injected with morpholinos for smad3a at 1–2 cell stage or treated at
2 hpf with Alk5-inhibitor LY364947. As shown with an arrowhead, morpholinos and drug treatment give similar results: increase of proliferative cells (ngn1) at tail tip,
decrease of differentiating cells (neuroD) and reduction of late differentiating motor neurons (mnx1). ngn1 is Tg(ngn1:GFP)sb1. neuroD is Tg(2.4 kb neurod:EGFP). mnx1 is Tg
(hlxb9:GFP)ml2. Quantiﬁcation of each frame is shown in Supplemental Table S3. Scale bar is 100 mm in all the images.
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smad2 morpholino give an appreciable reduction of 12xSBE-
depending reporter expression (Table 4). However, the different
techniques used to inhibit and study Smad2 in zebraﬁsh (this
work) and chicken (Miguez et al., 2013) (i.e., morpholino vs. short-
hairpin RNA; microinjection of eggs vs. electroporation of neural
tube; stable line vs. transient expression) can explain the differ-
ences. Alternatively, Smad2-3a-3b and 4 interact in different ways
in neural tube formation of the two animals.
Coinjection of the lowest effective doses of smad2 and 3a
morpholinos showed that the reporter is strictly smad3/4 dependant
with no smad2 dependent reporter activity. smad2 morpholino
induces a reporter decrease only when it causes a severe phenotype.
On the other hand, smad3a morpholino can inhibit reporter
expression at non teratogenic doses. Moreover, overexpression of
smad2 and 4 by injection of the corresponding mRNAs did not alter
GFP expression. Smad4 is indeed permissive for the Smad3 depen-
dant GFP expression. Interestingly, only smad3b overexpression
causes a reporter increase, while smad3a can induce GFP production
only in combination with smad3b. As seen in morpholino-directed
knockdown, the two smad3 isoforms seem to have similar, but not
identical roles in the activation of the reporter expression.
In any case, the 12xSBE line will be a useful tool, together with
a still missing Smad2 reporter line (possibly based on activin
response elements, ARE) (Chen et al., 1996), to dissect the func-
tional interactions between the TGFβ family speciﬁc transcrip-
tional effectors in vivo.
Characterization of Tg(12xSBE:nlsmCherry)ia15 line has been
completed by overexpressing smad7 and smad3b. Overexpression
of smad7 caused a drastic reduction of reporter activity in all
domains (Fig. 3). On the other hand, overexpression of smad3b by
plasmid injection led to a mosaic activity of smad3b and, conse-
quently, of the reporter (Fig. 3). An ectopic expression of mCherry
in Smad3-competent cells, as was evident, supports the idea that
muscle cells do not possess epigenetic mechanisms to inactivate
this pathway.
Confocal observations of the transgenic line show that in the
neural tube the reporter is active in cells surrounding the ventricular
zone (Fig. 4). This area is known to be a region in which genetic
signals lead neural progenitor cells to exit the cell cycle and begin
differentiation (Schmidt et al., 2013). To understand the role of
Smad3 activation in this area, the Tg(12xSBE:nlsmCherry)ia15 line
has been crossed with different transgenic lines expressing GFP in
different neuronal cells: Tg(ngn1:GFP)sb1, Tg(2.4 kb neurod:EGFP)
and Tg(mnx1:GFP)ml2. The observation of patterns of colocalization
has shown that reporter expression was activated in differentiating
neurons (neuroDþ cells) (Fig. S9). Colocalization of Smad3-
responsive cells with neuroDþ cells was high while a signiﬁcant
degree of colocalization was measured with ngn1þ cells at the tip of
the tail, where neuronal progenitors arise (Fig. S9). On the other
hand, committed cells (mnx1þ) seem to be Smad3/TGFβ1/2/3
negative (Fig. S9). From these observations we suspected that
TGFβ1/2/3 signaling could be active in ex-progenitor cells, which
exit the cell cycle and start differentiating. This hypothesis was
conﬁrmed after analyzing Smad3 signaling in the tail of double
transgenic embryos at 24 hpf, using somites as a molecular clock
(Fig. 5). At the onset of Smad3 signaling (t¼0), progenitor cells
(ngn1þ) coexpressed the reporter signal (Fig. 5). Colocalization was
maintained with differentiating neuronal cells (neuroDþ) (Fig. 5).
Committed motor neurons (mnx1þ) on the other hand, did not show
signiﬁcant colocalization at any of the time-points examined (Fig. 5).
The Smad3 control of proliferation is crucial during early-
postnatal differentiation of cerebellar neurons into postmitotic
neurons, by activation of cyclin-dependent kinase inhibitors p21,
p27 and markers of neuronal differentiation (Ueberham and
Arendt, 2013). A clear inhibitory function of Smad3 on neural
progenitors proliferation was observed in chickens developing a
spinal cord, where Smad3 also promotes differentiation of selected
neurons and glia (Garcia-Campmany and Marti, 2007). Both
immunohistochemistry for phospho-hystone3 on smad3a mor-
phant embryos at 24 hpf (Fig. 7A–B0) and LY364947-treated larvae
at 48 hpf (Fig. 7C–D0) and EdU proliferation assay on embryos
treated with Alk5 inhibitor, LY364947, (Fig. 7E–F0) showed a
massive increase of proliferating cells in many tissue compart-
ments, the nervous system (NS) included. All these experiments
have conﬁrmed that Alk4/5-Smad3 signaling negatively regulates
the cell cycle and is inactive in proliferating cells. Colocalization
studies have indicated that Smad3-responsive cells mainly corre-
spond to differentiating cells rather than proliferating and mature
cells in the NS. Pulse and chase EdU proliferation assay has
conﬁrmed that in 24 hpf Tg(12xSBE:EGFP)ia16 embryos GFP-
expressing cells are post-mitotic for the most part (Fig. 7G–H0).
We can conclude that Smad3 acts on the cell cycle by controlling
cell proliferation and it is expressed postmitotically at 24 hpf.
Having demonstrated that Smad3 is activated in the NS by
differentiating cells, we have carried out some functional in vivo
studies blocking Alk4/5-Smad3 activity in embryos of the transgenic
lines used for colocalization measurements: Tg(ngn1:GFP)sb1, Tg
(2.4 kb neurod:EGFP) and Tg(mnx1:GFP)ml2. Both genetic and
pharmacological TGFβ1/2/3 inhibition led us to similar conclusions
(Fig. 7): Smad3 mediated TGFβ signaling is important to maintain a
balance between progenitor and committed cells and a decrease in
TGFβ signaling activity increases the number of undifferentiated
cells (ngn1þ cells) and a decrease of committed cells (mnx1þ).
Another conclusion from our studies is about Smad3a and 3b
roles in NS development: both Smad3 isoforms can recognize
CAGA box and direct reporter expression in the neural tube.
Functional in vivo experiments with transgenics conﬁrmed that
the two isoforms are equally involved in neurogenesis as the
effects on the neural markers expression seemed to be very
similar. Coinjection of the 2 morpholinos did not cause a further
impairment in the neural tube formation, while the embryo body
appeared to be more severely altered (shortened embryo, smaller
malformed head) (not shown). This let us conclude that at least in
neural tube formation Smad3a and 3b have similar levels of
additive genetic effects.
Through these assays, we can hypothesize that the 12xSBE line
is responsive to TGFβ1/2/3-Alk4/5-Smad3- signaling drugs,
depends on Smad3 activation and it is inhibited by Smad7. In
addition, both zebraﬁsh Smad3 isoforms seem to recognize CAGA
box with similar efﬁcacy and participate equally in differentiation
of the neural tube. According to this data, Smad3 mediated TGFβ
signaling seems to have a role in CNS development by controlling
the progenitor to precursor switch.
Finally, this work aims to showcase an alternative approach in
studying biological mechanisms. The current paradigm of dissect-
ing gene function usually begins with gene identiﬁcation, the
deﬁnition of its expression domain, followed by knockdown and
description of the phenotypic effects. However, this approach is
limited if one considers that dissection of gene functions and
phenotypes needs the precise identiﬁcation of the cells in
which the genes or pathways are operating, as well as the under-
standing of the temporal dynamic of gene activity computed by
cells in vivo. The approach used in this work is an attempt to
overcome this limitation: we started from the strongest expression
of a functional reporter to identify the tissues in which a
transcription factor (Smad3) is activated by a main developmental
signaling pathway (TGFβ). Here we analyzed the functions of
Smad3 in previously neglected tissues and cell types – the
periventricular cells of the neural tube -that we reveal as main
targets of TGFβ ligands, thus unveiling targets of pleiotropic
signals coming from a different tissues equipped with multiple
inducing abilities.
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